Department of Health Sciences

Keyphrases

1. Spinal Cord Injury 100%
2. Chronic Low Back Pain (cLBP) 75%
3. Mental Imagery 75%
4. Informal Caregivers 70%
5. During Exercise 66%
6. Systematic Literature Review 62%
7. Liposomal 62%
8. Patient Care 57%
9. Pressure Ulcer 57%
10. Risk of Bias 56%
11. Type 2 Diabetes Mellitus (T2DM) 50%
12. Blood Glucose 50%
13. Scoping Review 50%
14. Mixed Food 50%
15. Food Plants 50%
16. Comorbidity 50%
17. Deformational Plagiocephaly 50%
18. Chitosan Nanogel 50%
19. Nurse's Role 50%
20. Meta-analysis 50%
21. Chronic Kidney Disease 50%
22. Active Ingredients 50%
23. Scorpion Peptide 50%
24. Novel Antimicrobials 50%
25. Green Extraction 50%
26. Reliability Testing 50%
27. Natural Biomaterials 50%
28. Synthetic Biomaterials 50%
29. Hippotherapy 50%
30. Walking Capacity 50%
31. Fatigue Dynamics 50%
32. Compounding Pharmacy 50%
33. Infantile Hemangioma 50%
34. Nursing Work Environment 50%
35. Pharmacodynamics 50%
36. Human Epidermal Growth Factor Receptor 2 (HER2) 50%
37. Cyclin-dependent Kinase 4 (CDK4) 50%
38. MHealth Intervention 50%
39. Fascin-1 50%
40. Functional Performance 50%
41. Therapeutic Exercise 50%
42. Self-use 50%
43. Functional Quality 50%
44. Nanosystems 50%
45. Test Validity 50%
46. Energy Expenditure 50%
47. Low Back Pain 50%
48. Wound Care 50%
49. In Cancer 50%
50. Biomedical Applications 50%
51. Propranolol 50%
52. Dynamic Balance 50%
53. Advanced Drug Delivery 50%
54. Musculoskeletal Pain 50%
55. Greek 50%
56. Patient Outcomes 50%
57. Content Validity 50%
58. Safety Profile 50%
59. Metastatic Breast Cancer 50%
60. Cancer Metastasis 50%
61. Quality of Life 50%
62. Mobile Application 50%
63. Pain Reduction 50%
64. Multiple Sclerosis 50%
65. Caregivers 50%
66. Transformational Leadership 50%
67. Knee Joint Position Sense 50%
68. Gym Workout 50%
69. Imagery Use 50%
70. Odontites 50%
71. Acanthamoeba 50%
72. Flexibility Performance 50%
73. Bacterial Communication 50%
74. LuxS 50%
75. Antileishmanial Activity 50%
76. Guidance Documents 50%
77. Vulvovaginal Candidiasis 50%
78. Vaginal Suppository 50%
79. Natamycin 50%
80. Lactulose 50%
81. Outpatient Interventions 50%
82. Epilepsy Care 50%
83. Liposomes 42%
84. M-group 41%
85. Chitosan 40%
86. Scale Levels 37%
87. Mobile Health Applications 37%
88. PubMed 35%
89. Antimicrobial 33%
90. Scorpion Venom Peptide 33%
91. Fatigue State 33%
92. Resting State 33%
93. Prediction Interval 30%
94. Okra 30%
95. Unripe Plantain 30%
96. Bitter Yam 30%
97. Bioactive Molecules 30%
98. Patient Support 30%
99. Metastasis 30%
100. Intervention Group 30%